BIRC2 and breast carcinoma: Breast cancer patients with distant organ metastases showed 16.83 mean fold increased mRNA expression, while nonmetastatic breast cancer patients showed 12.92 mean fold increased cIAP-1 mRNA expression, and the difference among them was found to be significant (p=0.008).